You have not yet registered? Get your account for free.
Forgot Password? We will send you a reset link
27 March 2024
RELIEF THERAPEUTICS Holding SA to Hold Extraordinary General Meeting
22 March 2024
Relief Therapeutics Enters into Exclusive U.S. License and Supply Agreement with Eton Pharmaceuticals for PKU GOLIKE
28 February 2024
Relief Therapeutics Renews CHF 50 million Share Subscription Facility
5 December 2023
Relief Therapeutics Shifts Commercial Operations to Partnership Model, Focusing on Efficient Patient Access and R&D Growth
22 November 2023
Relief Therapeutics Announces CEO Transition
10 October 2023
Relief Therapeutics Announces that more than 400,000 of its ADRs are currently outstanding and that, as a result, the Company has achieved an Important NASDAQ Initial Listing Milestone